Skip to main content
SpringerLink
Log in

Donor Factors Similarly Impact Survival Outcome After Liver Transplantation in Hepatocellular Carcinoma and Non-hepatocellular Carcinoma Patients

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Many have advocated the preferential use of high risk allografts for hepatocellular carcinoma patients undergoing liver transplantation. Hepatocellular carcinoma (HCC) patients tend to have relatively preserved liver function, and their outcome is felt to be driven largely by tumor-related factors.

Aim

The aim of this study was to compare the relative importance of donor versus recipient factors on post-orthotopic liver transplantation survival among HCC and non-HCC recipients.

Methods

The study group included Scientific Registry of Transplant Recipients data on adult recipients of deceased donor liver transplants from February 2002 through December 2008. Recipients were classified as HCC based on MELD exception applications and were compared to all other recipients. Predictors of post-LT survival were identified by Cox regression. To test whether donor factors have less impact on survival in HCC patients, interaction terms were created between HCC diagnosis and donor factors.

Results

Of the 40,212 DDLTs during the study period, 29,020 (72 %) met study criteria. A total of 7,786 (27 %) were transplanted with a diagnosis of HCC. The mean donor risk index was 1.5 in both cohorts. The 1-/5-year survival was 88 %/68 % and 87 %/74 % among HCC and non-HCC recipients, respectively (p < 0.0001). On multivariate analysis, there was no statistically significant interaction between HCC diagnosis and DRI (HR 0.94, p = 0.317). Likewise, no interaction was seen between HCC diagnosis and individual donor factors. In both groups, donor and recipient factors carried similar weight in determining post-LT survival.

Conclusions

Contrary to previous assumptions, donor factors play a similar role in determining survival post-LT among HCC patients and non-HCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–1127.

    Article  CAS  PubMed  Google Scholar 

  2. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5–S16.

    Article  PubMed  Google Scholar 

  3. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25:181–200.

    Article  PubMed  Google Scholar 

  4. Pelletier SJ, Fu S, Thyagarajan V, et al. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl. 2009;15:859–868.

    Article  PubMed  Google Scholar 

  5. Zavaglia C, De Carlis L, Alberti AB, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol. 2005;100:2708–2716.

    Article  PubMed  Google Scholar 

  6. Bertuzzo VR, Cescon M, Ravaioli M, et al. Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. Transplantation. 2011;91:1279–1285.

    Article  PubMed  Google Scholar 

  7. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080–1086.

    Article  CAS  PubMed  Google Scholar 

  8. Ioannou GN, Perkins JD, Carithers RL. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology. 2008;134:1342–1351.

    Article  PubMed  Google Scholar 

  9. Saab S, Wang V, Ibrahim AB, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl. 2003;9:473–476.

    Article  PubMed  Google Scholar 

  10. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783–790.

    Article  CAS  PubMed  Google Scholar 

  11. Angelico M, Cillo U, Fagiuoli S, et al. Liver match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis. 2011;43:155–164.

    Article  PubMed  Google Scholar 

  12. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134:1752–1763.

    Article  PubMed  Google Scholar 

  13. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699.

    Article  CAS  PubMed  Google Scholar 

  14. Volk ML, Reichert HA, Lok ASF, et al. Variation in organ quality between liver transplant centers. Am J Transplant. 2011;11:958–964.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Washburn K, Edwards E, Harper A, et al. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant. 2010;10:1643–1648.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Taubman Medical Center, University of Michigan, 1500 E. Medical Center Drive, Room 3912, SPC 5362, Ann Arbor, MI, 48109, USA

    Reena J. Salgia & Michael L. Volk

  2. Arbor Research Collaborative for Health, 340 E. Huron Street, Suite 300, Ann Arbor, MI, 48104, USA

    Nathan P. Goodrich

  3. Department of Internal Medicine, University of Texas Southwestern Medical Center, Professional Office Building 1, Suite 520L, 5959 Harry Hines Blvd., Dallas, TX, USA

    Jorge A. Marrero

Authors
  1. Reena J. Salgia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nathan P. Goodrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jorge A. Marrero
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael L. Volk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reena J. Salgia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salgia, R.J., Goodrich, N.P., Marrero, J.A. et al. Donor Factors Similarly Impact Survival Outcome After Liver Transplantation in Hepatocellular Carcinoma and Non-hepatocellular Carcinoma Patients. Dig Dis Sci 59, 214–219 (2014). https://doi.org/10.1007/s10620-013-2883-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-013-2883-7

Keywords

Search

Navigation